相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Macrophage targeting in cancer
Martha Lopez-Yrigoyen et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2021)
Tumor-Infiltrating Natural Killer Cells
Beatriz Cozar et al.
CANCER DISCOVERY (2021)
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inibitor Response
Meagan Montesion et al.
CANCER DISCOVERY (2021)
A Phase II, Prospective, Randomized, Multicenter, Open-Label Study of GX-188E, an HPV DNA Vaccine, in Patients with Cervical Intraepithelial Neoplasia 3
Youn Jin Choi et al.
CLINICAL CANCER RESEARCH (2020)
Tissue Determinants of Human NK Cell Development, Function, and Residence
Pranay Dogra et al.
CELL (2020)
Dendritic cell development: A personal historical perspective
Ken Shortman
MOLECULAR IMMUNOLOGY (2020)
Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1
Michael D. Crowther et al.
NATURE IMMUNOLOGY (2020)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
Shelly Kalaora et al.
NATURE COMMUNICATIONS (2020)
The NKG2A-HLA-E Axis as a Novel Checkpoint in the Tumor Microenvironment
Linda Borst et al.
CLINICAL CANCER RESEARCH (2020)
Expanded clinical-grade membrane-bound IL-21/4-1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo
Xiang-Yu Zhao et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection
Cedric Bosteels et al.
IMMUNITY (2020)
Pembrolizumab plus allogeneic NK cells in advanced non-small cell lung cancer patients
Mao Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy
Maud Mayoux et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity
Lauren K. Zebertavage et al.
SCIENTIFIC REPORTS (2020)
A conserved dendritic-cell regulatory program limits antitumour immunity
Barbara Maier et al.
NATURE (2020)
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Keisuke Yamamoto et al.
NATURE (2020)
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
Junyun Lai et al.
NATURE IMMUNOLOGY (2020)
Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer
David Y. Oh et al.
CELL (2020)
Cross-dressing of CD8α+ Dendritic Cells with Antigens from Live Mouse Tumor Cells Is a Major Mechanism of Cross-priming
Alok Das Mohapatra et al.
CANCER IMMUNOLOGY RESEARCH (2020)
HLA-G: A New Immune Checkpoint in Cancer?
Danielle Krijgsman et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
cDC1 prime and are licensed by CD4+T cells to induce anti-tumour immunity
Stephen T. Ferris et al.
NATURE (2020)
The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies
Tobias Bald et al.
NATURE IMMUNOLOGY (2020)
TIGIT in cancer immunotherapy
Joe-Marc Chauvin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade
Eduardo Bonavita et al.
IMMUNITY (2020)
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial
Jin Won Youn et al.
LANCET ONCOLOGY (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Harnessing Tumor Mutations for Truly Individualized Cancer Vaccines
Mathias Vormehr et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
Simona Sivori et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Peptide trimming by endoplasmic reticulum aminopeptidases: Role of MHC class I binding and ERAP dimerization
Irini Evnouchidou et al.
HUMAN IMMUNOLOGY (2019)
Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer
Mirco Compagnone et al.
HUMAN IMMUNOLOGY (2019)
Neoantigen-directed immune escape in lung cancer evolution
Rachel Rosenthal et al.
NATURE (2019)
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
Daisuke Ennishi et al.
CANCER DISCOVERY (2019)
Memory NK Cell Features Exploitable in Anticancer Immunotherapy
Cristina Capuano et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
Mikhail Binnewies et al.
CELL (2019)
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
Linda Hammerich et al.
NATURE MEDICINE (2019)
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients
Joseph Cursons et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Immunotherapeutic effects of intratumoral nanoplexed poly I:C
M. Angela Aznar et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes
Andrea Castro et al.
BMC MEDICAL GENOMICS (2019)
Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours
Kate L. Lowe et al.
CANCER TREATMENT REVIEWS (2019)
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Laurent Gauthier et al.
CELL (2019)
Rebalancing Protein Homeostasis Enhances Tumor Antigen Presentation
Alex M. Jaeger et al.
CLINICAL CANCER RESEARCH (2019)
DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade
Guo-Liang Chew et al.
DEVELOPMENTAL CELL (2019)
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
Aude G. Chapuis et al.
NATURE MEDICINE (2019)
Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasmas
Cansu Cimen Bozkus et al.
CANCER DISCOVERY (2019)
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta et al.
CANCER DISCOVERY (2019)
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy
Beatriz Sanchez-Correa et al.
CANCERS (2019)
Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
Ziqing Chen et al.
CANCERS (2019)
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
Marian L. Burr et al.
CANCER CELL (2019)
Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer
Alexey Morozov et al.
FRONTIERS IN ONCOLOGY (2019)
Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity
Greta Garrido et al.
NATURE COMMUNICATIONS (2019)
Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells
Evelyn Menares et al.
NATURE COMMUNICATIONS (2019)
Transposable element expression in tumors is associated with immune infiltration and increased antigenicity
Yu Kong et al.
NATURE COMMUNICATIONS (2019)
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer
Margaret L. Axelrod et al.
CLINICAL CANCER RESEARCH (2019)
Plasmacytoid Dendritic Cells: Development, Regulation, and Function
Boris Reizis
IMMUNITY (2019)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al.
NATURE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy
John-Michael Williford et al.
SCIENCE ADVANCES (2019)
The Dark Side of IFN-: Its Role in Promoting Cancer Immunoevasion
Marija Mojic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells
Stefanie Maurer et al.
ONCOIMMUNOLOGY (2018)
HLA and proteasome expression body map
Sebastian Boegel et al.
BMC MEDICAL GENOMICS (2018)
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Wanqiang Sheng et al.
CELL (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
Andreas T. Bjorklund et al.
CLINICAL CANCER RESEARCH (2018)
Natural killer cell education in human health and disease
Jeanette E. Boudreau et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy
Marie de Charette et al.
HAEMATOLOGICA (2018)
Tumor-associated calreticulin variants functionally compromise the peptide loading complex and impair its recruitment of MHC-I
Najla Arshad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
Nikolaos Zacharakis et al.
NATURE MEDICINE (2018)
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Kevin C. Barry et al.
NATURE MEDICINE (2018)
Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy
Marie de Charette et al.
HAEMATOLOGICA (2018)
The role of polymorphic ERAP1 in autoinflammatory disease
Emma Reeves et al.
BIOSCIENCE REPORTS (2018)
Emerging Cellular Therapies for Cancer
Sonia Guedan et al.
Annual Review of Immunology (2018)
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Christopher S. Garris et al.
IMMUNITY (2018)
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma
Christof C. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Design of amidobenzimidazole STING receptor agonists with systemic activity
Joshi M. Ramanjulu et al.
NATURE (2018)
Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration
Yoong Wearn Lim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
WDFY4 is required for cross-presentation in response to viral and tumor antigens
Derek J. Theisen et al.
SCIENCE (2018)
HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome
Patricia T. Illing et al.
NATURE COMMUNICATIONS (2018)
How ERAP1 and ERAP2 Shape the Peptidomes of Disease-Associated MHC-I Proteins
Jose A. Lopez de Castro
FRONTIERS IN IMMUNOLOGY (2018)
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Jan P. Boettcher et al.
TRENDS IN CANCER (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Valsamo Anagnostou et al.
CANCER DISCOVERY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Identification of essential genes for cancer immunotherapy
Shashank J. Patel et al.
NATURE (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
Hagop Kantarjian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells
Michel Enamorado et al.
NATURE COMMUNICATIONS (2017)
Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer
Filippo Veglia et al.
NATURE COMMUNICATIONS (2017)
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman et al.
NATURE COMMUNICATIONS (2017)
Proofreading of Peptide-MHC Complexes through Dynamic Multivalent interactions
Christoph Thomas et al.
FRONTIERS IN IMMUNOLOGY (2017)
HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance
Barbara Seliger et al.
ONCOIMMUNOLOGY (2017)
Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion
Lee A. Albacker et al.
PLOS ONE (2017)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan et al.
CELL (2017)
Characterizing neoantigens for personalized cancer immunotherapy
Aude-Helene Capietto et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Yonit Lavin et al.
CELL (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
Alfonso R. Sanchez-Paulete et al.
CANCER DISCOVERY (2016)
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
Edward W. Roberts et al.
CANCER CELL (2016)
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Jianjun Gao et al.
CELL (2016)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species
Martin Guilliams et al.
IMMUNITY (2016)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
Preventing tumor escape by targeting a post-proteasomal trimming independent epitope
Ana Textor et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
ERAAP Shapes the Peptidome Associated with Classical and Nonclassical MHC Class I Molecules
Niranjana A. Nagarajan et al.
JOURNAL OF IMMUNOLOGY (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Targeting natural killer cells in cancer immunotherapy
Camille Guillerey et al.
NATURE IMMUNOLOGY (2016)
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Eric Tran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
PGE2 induced in and released by dying cells functions as an inhibitory DAMP
Sho Hangai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
NLRC5/MHC class I transactivator is a target for immune evasion in cancer
Sayuri Yoshihama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Present Yourself! By MHC Class I and MHC Class II Molecules
Kenneth L. Rock et al.
TRENDS IN IMMUNOLOGY (2016)
Molecular mechanism of peptide editing in the tapasin-MHC I complex
Olivier Fisette et al.
SCIENTIFIC REPORTS (2016)
JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms
Kathrin Schoenberg et al.
CANCER RESEARCH (2015)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
Juan R. Cubillos-Ruiz et al.
CELL (2015)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Santiago Zelenay et al.
CELL (2015)
The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35-specific T-cell recognition
Martin Keller et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most?
Hanneke W. M. van Deutekom et al.
IMMUNOGENETICS (2015)
Multiple Structural and Epigenetic Defects in the Human Leukocyte Antigen Class I Antigen Presentation Pathway in a Recurrent Metastatic Melanoma Following Immunotherapy
Chien-Chung Chang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation
Michal Bassani-Sternberg et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes
Sachet A. Shukla et al.
NATURE BIOTECHNOLOGY (2015)
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
Nader Yatim et al.
SCIENCE (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
Erika Vacchelli et al.
SCIENCE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation
Marianna Papaspyridonos et al.
NATURE COMMUNICATIONS (2015)
Loss of heterozygosity at the human leukocyte antigen locus in thymic epithelial tumors
Yuan Chen et al.
THORACIC CANCER (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
MSIsensor: microsatellite instability detection using paired tumor-normal sequence data
Beifang Niu et al.
BIOINFORMATICS (2014)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
Yong-Chen Lu et al.
CLINICAL CANCER RESEARCH (2014)
Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer
Wei Cao et al.
JOURNAL OF IMMUNOLOGY (2014)
Label-Free Quantitative Proteomics Reveals the Dynamics of Proteasome Complexes Composition and Stoichiometry in a Wide Range of Human Cell Lines
Bertrand Fabre et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Critical Role of Endoplasmic Reticulum Aminopeptidase 1 in Determining the Length and Sequence of Peptides Bound and Presented by HLA-B27
Liye Chen et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Secretory pathways generating immunosuppressive NKG2D ligands New targets for therapeutic intervention
Aroa Baragano Raneros et al.
ONCOIMMUNOLOGY (2014)
A role for naturally occurring alleles of endoplasmic reticulum aminopeptidases in tumor immunity and cancer pre-disposition
Efstratios Stratikos et al.
FRONTIERS IN ONCOLOGY (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation
Lillian Cohn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Induction of Protective Antitumor Immunity through Attenuation of ERAAP Function
Edward James et al.
JOURNAL OF IMMUNOLOGY (2013)
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
J. Nangalia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
MHC Class I-Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia
Mark Cobbold et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice
Santiago Zelenay et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Analysis of the Processing of Seven Human Tumor Antigens by Intermediate Proteasomes
Benoit Guillaume et al.
JOURNAL OF IMMUNOLOGY (2012)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
NLRC5: a newly discovered MHC class I transactivator (CITA)
Torsten B. Meissner et al.
MICROBES AND INFECTION (2012)
Cross-dressed CD8α+/CD103+ dendritic cells prime CD8+ T cells following vaccination
Lijin Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
Madhavi Challa-Malladi et al.
CANCER CELL (2011)
Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics
Sun Qifeng et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients
Esther M. de Kruijf et al.
JOURNAL OF IMMUNOLOGY (2010)
Lipid accumulation and dendritic cell dysfunction in cancer
Donna L. Herber et al.
NATURE MEDICINE (2010)
NLR family member NLRC5 is a transcriptional regulator of MHC class I genes
Torsten B. Meissner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules
Benoit Guillaume et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer
Q. Ye et al.
TISSUE ANTIGENS (2010)
Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
David Sancho et al.
NATURE (2009)
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
Takuya Osada et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
The quality control of MHC class I peptide loading
Pamela A. Wearsch et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells (vol 118, pg 1099, 2008)
Yoshiyuki Takahashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity
Kai Hildner et al.
SCIENCE (2008)
In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides
Gianna Elena Hammer et al.
NATURE IMMUNOLOGY (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses
Laurence Chapatte et al.
CANCER RESEARCH (2006)
Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines
D Fruci et al.
JOURNAL OF IMMUNOLOGY (2006)
Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation
J Chapiro et al.
JOURNAL OF IMMUNOLOGY (2006)
Coordinated downregulation of the antigen presentation machinery and HLA class I/β2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer
JM Romero et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation
SJ Park et al.
JOURNAL OF IMMUNOLOGY (2004)
O-linked glycosylation in the mammary gland: Changes that occur during malignancy
JM Burchell et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2001)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
VEGF as a Mediator of tumor-associated immunodeficiency
JE Ohm et al.
IMMUNOLOGIC RESEARCH (2001)
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells
S Morel et al.
IMMUNITY (2000)
分享论文
